‌

US Patent 12016842 Methods of using anti-CD79b immunoconjugates

Patent 12016842 was granted and assigned to Genentech on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Dan Lu0

Jamie Harue Hirata0

Yu-Waye Chu0

Shang-Fan Yu0

Michael Wenger0

Andrew Polson0

Date of Patent

June 25, 2024

0

Patent Application Number

172308610

Date Filed

April 14, 2021

0

Patent Citations

US Patent 7091186 None

0

US Patent 7097840 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates

0

US Patent 7098305 Sustained release of microcrystalline peptide suspensions

0

US Patent 7098308 Pentapeptide compounds and uses related thereto

0

US Patent 7202346 Antibodies to non-shed Muc1 and Muc16, and uses thereof

0

US Patent 7276372 Antibodies against GPR64 and uses thereof

0

US Patent 7288248 Antibodies against cancer antigen TMEFF2 and uses thereof

0

US Patent 7303749 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

Patent abstract

Provided herein are methods of treating B-cell proliferative disorders in particular Follicular Lymphoma and/or Diffuse Large B-Cell Lymphoma using immunoconjugates comprising anti-CD79b antibodies in combination with additional therapeutic agents.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12016842 Methods of using anti-CD79b immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.